Geeta Madathil Govindaraj, Abhinav Jain, Athulya Edavazhippurath, Rahul C Bhoyar, Dhananjayan Dhanasooraj, Anushree Mishra, Vishu Gupta, Mohandas Nair, P M Shiny, Ramya Uppuluri, Anoop Kumar, Atul Kashyap, V T Ajith Kumar, Gireesh Shankaran, Vigneshwar Senthivel, Mohamed Imran, Mohit Kumar Divakar, Sneha Sawant, Aparna Dalvi, Manisha Madkaikar, Revathi Raj, Sridhar Sivasubbu, Vinod Scaria
X-linked agammaglobulinemia (XLA) is an X-linked recessive primary immunodeficiency disorder caused due to a pathogenic variant in the Bruton tyrosine (BTK) gene with an incidence of 1:379,000 live births and 1:190,000 male births. Patients affected with XLA present with recurrent infections of the gastrointestinal and respiratory tracts. Here we report the first case series of 17 XLA patients of 10 South Indian families with a wide spectrum of clinical and genetic features. In our cohort, patients presented mainly with recurrent pneumonia, gastrointestinal infection, otitis media, pyoderma, abscesses, empyema, arthritis, and osteomyelitis...
April 2022: Human Immunology